{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:53:36Z","timestamp":1785488016429,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to determine the recurrence rate of patients who did not have interval cholecystectomy after treatment with percutaneous cholecystostomy and to investigate the factors that may affect the recurrence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients who did not undergo interval cholecystectomy after percutaneous cholecystostomy treatment between 2015 and 2021 were retrospectively screened for recurrence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>36.3% of the patients had recurrence. Recurrence was found more frequently in patients with fever symptoms at the time of admission to the emergency department (p\u2009=\u20090.003). Recurrence was found to be more frequent in those who had a previous cholecystitis attack (p\u2009=\u20090.016). It was determined that patients with high lipase and procalcitonin levels had statistically more frequent attacks (p\u2009=\u20090.043, p\u2009=\u20090.003). It was observed that the duration of catheter insertion was longer in patients who had relapses (p\u2009=\u20090.019). The cut-off value for lipase was calculated as 15.5, and the cut-off value for procalcitonin as 0.955, in order to identify patients at high risk for recurrence. In the multivariate analysis for the development of recurrence, presence of fever, a history of previous cholecystitis attack, lipase value higher than 15.5 and procalcitonin value higher than 0.955 were found to be risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Percutaneous cholecystostomy is an effective treatment method in acute cholecystitis. Insertion of the catheter within the first 24\u00a0h may reduce the recurrence rate. Recurrence is more common in the first 3 months following removal of the cholecystostomy catheter. Having a previous history of cholecystitis attack, fever symptom at the time of admission, elevated lipase and procalcitonin are risk factors for recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-023-02042-2","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T16:02:10Z","timestamp":1685030530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Factors affecting the recurrence of acute cholecystitis after treatment with percutaneous cholecystostomy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7458-828X","authenticated-orcid":false,"given":"Korhan","family":"Tuncer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-3198","authenticated-orcid":false,"given":"Gizem","family":"Kilinc Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-1446","authenticated-orcid":false,"given":"B\u00fclent","family":"\u00c7al\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"2042_CR1","first-page":"330","volume":"49","author":"RW Radder","year":"1980","unstructured":"Radder RW. Ultrasonically guided percutaneous catheter drainage for gallbladder empyema. Diagn Imaging. 1980;49:330\u20133.","journal-title":"Diagn Imaging"},{"key":"2042_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jgh.14611","volume":"34","author":"JK Park","year":"2019","unstructured":"Park JK, Yang J, Wi JW, Park JK, Lee KH, Lee KT, et al. Long-term outcome and recurrence factors after percutaneous cholecystostomy as a definitive treatment for acute cholecystitis. J Gastroenterol Hepatol. 2019;34:784\u201390.","journal-title":"J Gastroenterol Hepatol"},{"key":"2042_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jacr.2012.02.019","volume":"9","author":"R Duszak Jr","year":"2012","unstructured":"Duszak R Jr, Behrman SW. National trends in percutaneouscholecystostomy between 1994 and 2009: perspectives fromMedicare provider claims. J Am Coll Radiol. 2012;9:474\u20139.","journal-title":"J Am Coll Radiol"},{"key":"2042_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1477-2574.2009.00052.x","volume":"11","author":"A Winbladh","year":"2009","unstructured":"Winbladh A, Gullstrand P, Svanvik J, Sandstr\u00f6m P. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB. 2009;11:183\u201393.","journal-title":"HPB"},{"key":"2042_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1477-2574.2012.00610.x","volume":"15","author":"P Sanjay","year":"2013","unstructured":"Sanjay P, Mittapalli D, Marioud A, White RD, Ram R, Alijani A. Clinical outcomes of a percutaneous cholecystostomy for acute cholecystitis: a multicentre analysis. HPB (Oxford). 2013;15:511\u20136.","journal-title":"HPB (Oxford)"},{"key":"2042_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/000313481307900529","volume":"79","author":"M Li","year":"2013","unstructured":"Li M, Li N, Ji W, Quan Z, Wan X, Wu X, et al. Percutaneous cholecystostomy is a definitive treatment for acute cholecystitis in elderly high-risk patients. Am Surg. 2013;79:524\u20137.","journal-title":"Am Surg"},{"key":"2042_CR7","doi-asserted-by":"publisher","unstructured":"Garcia RC, Rodriguez PS, Garcia MR. Colecistostom\u00eda percut\u00e1nea como tratamiento de la colecistitis aguda en pacientes con alto riesgo quir\u00fargico. Radiologia 2015. https:\/\/doi.org\/10.1016\/j.rx.2015.09.006","DOI":"10.1016\/j.rx.2015.09.006"},{"key":"2042_CR8","doi-asserted-by":"publisher","unstructured":"Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41\u201354. https:\/\/doi.org\/10.1002\/jhbp.515. Epub 2018 Jan 9.","DOI":"10.1002\/jhbp.515"},{"key":"2042_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jhbp.516","volume":"25","author":"K Okamoto","year":"2018","unstructured":"Okamoto K, Suzuki K, Takada T, Strasberg SM, Asbun HJ, Endo I, et al. Tokyo Guidelines 2018:flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:55\u201372.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2042_CR10","first-page":"299","volume":"83","author":"H Kiviniemi","year":"1998","unstructured":"Kiviniemi H, Makela JT, Autio R, Tikkakoski T, Leinonen S, Siniluoto T, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg. 1998;83:299\u2013302.","journal-title":"Int Surg"},{"key":"2042_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/TA.0b013e31827890e1","volume":"74","author":"C Mestral","year":"2013","unstructured":"Mestral C, Gomez D, Haas B, Zagorski B, Rotstein OD, Nathens AB. Cholecystostomy: a bridge to hospital discharge but not delayed cholecystectomy. J Trauma Acute Care Surg. 2013;74:175\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"2042_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.surg.2013.12.026","volume":"155","author":"YR Chang","year":"2014","unstructured":"Chang YR, Ahn YJ, Jang JY, Kang MJ, Kwon W, Jung WH, et al. Percutaneous cholecystostomy for acute cholecystitis in patients with high comorbidity and re-evaluation of treatment efficacy. Surgery. 2014;155:615\u201322.","journal-title":"Surgery"},{"key":"2042_CR13","doi-asserted-by":"crossref","unstructured":"Wang CH, Wu CY, Yang JCT, Lien WC, Wang HP, Liu KL et al. Long-term outcomes of patients with acute cholecystitis after successful percutaneous cholecystostomy treatment and the risk factors for recurrence: a decade experience at a single center. PLoS One 2016 Jan 28;11(1):e0148017.","DOI":"10.1371\/journal.pone.0148017"},{"key":"2042_CR14","first-page":"673","volume":"32","author":"CR Morris","year":"1952","unstructured":"Morris CR, Hohf RP, Ivy AC. An experimental study of the role of stasis in the etiology of cholecystitis. Surgery. 1952;32:673\u201385.","journal-title":"Surgery"},{"key":"2042_CR15","doi-asserted-by":"crossref","unstructured":"Bergman S, Al-Bader M, Sourial N, Vedel I, Hann WC, BilekAJ et al. Recurrence of biliary disease following non-operativemanagement in elderly patients. Surg Endosc. 2015 Feb 12.","DOI":"10.1007\/s00464-015-4098-9"},{"key":"2042_CR16","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1007\/s11605-012-1965-8","volume":"16","author":"YC Hsieh","year":"2012","unstructured":"Hsieh YC, Chen CK, Su CW, Chan CC, Huo TI, Liu CJ, et al. Outcome after percutaneous cholecystostomy for acute cholecystitis: a single-center experience. J Gastrointest Surg. 2012;16:1860\u20138.","journal-title":"J Gastrointest Surg"},{"key":"2042_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2214\/ajr.163.2.8037026","volume":"163","author":"GW Boland","year":"1994","unstructured":"Boland GW, Lee MJ, Leung J, Mueller PR. Percutaneous cholecystostomy in critically ill patients: early response and final outcome in 82 patients. AJR Am J Roentgenol. 1994;163:339\u201342.","journal-title":"AJR Am J Roentgenol"},{"key":"2042_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jvir.2011.09.030","volume":"23","author":"T Joseph","year":"2012","unstructured":"Joseph T, Unver K, Hwang GL, Rosenberg J, Sze DY, Hashimi S, et al. Percutaneous cholecystostomy for acute cholecystitis: ten-year experience. J Vasc Interv Radiol. 2012;23:83\u20138e1.","journal-title":"J Vasc Interv Radiol"},{"key":"2042_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/00365520701851673","volume":"43","author":"P Leveau","year":"2008","unstructured":"Leveau P, Andersson E, Carlgren I, Willner J, Andersson R. Percutaneous cholecystostomy: a bridge to surgery or definite management of acute cholecystitis in high-risk patients? Scand J Gastroenterol. 2008;43:593\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"2042_CR20","first-page":"1497","volume":"55","author":"JP Ha","year":"2008","unstructured":"Ha JP, Tsui KK, Tang CN, Siu WT, Fung KH, Li MK. Cholecystectomy or not after percutaneous cholecystostomy for acute calculous cholecystitis in high-risk patients. Hepatogastroenterology. 2008;55:1497\u2013502.","journal-title":"Hepatogastroenterology"},{"issue":"01","key":"2042_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.29271\/jcpsp.2022.01.20","volume":"32","author":"MA \u00dcst\u00fcner","year":"2022","unstructured":"\u00dcst\u00fcner MA, Deniz A. Timing of Percutaneous Cholecystostomy. J Coll Physicians Surg Pak. 2022;32(01):20\u20134.","journal-title":"J Coll Physicians Surg Pak"},{"key":"2042_CR22","doi-asserted-by":"crossref","unstructured":"Zarour S, Imam A, Kouniavsky G, Lin G, Zbar A, Mavor E. Percutaneous cholecystostomy in the management of high risk patients present in with acute cholecystitis: timing and outcome at a single institution. Am J Surg 2017; 214; 456 \u2013 61.","DOI":"10.1016\/j.amjsurg.2017.01.030"},{"issue":"3","key":"2042_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00464-015-4290-y","volume":"30","author":"A Bickel","year":"2016","unstructured":"Bickel A, Hoffman RS, Loberant N, Weiss M, Eitan A. Timing of percutaneous cholecystostomy affects conversion rate of delayed laparoscopic cholecystectomy for severe acutecholecystitis. Surg End Scopy. 2016;30(3):1028\u201333.","journal-title":"Surg End Scopy"},{"issue":"27","key":"2042_CR24","doi-asserted-by":"publisher","first-page":"e1096","DOI":"10.1097\/MD.0000000000001096","volume":"94","author":"CK Chou","year":"2015","unstructured":"Chou CK, Lee KC, Chan CC, Perng CL, Chen CK, Fang WL, et al. Early percutaneous cholecystostomy in severe acute cholecystitis reduces the complication rate and duration of hospital stay. Medicine. 2015;94(27):e1096.","journal-title":"Medicine"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-02042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-023-02042-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-023-02042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T16:03:45Z","timestamp":1685030625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-023-02042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1186\/s12893-023-02042-2","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"29 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted retrospectively and approved by the local ethics committee of University of Health Sciences Tepecik Training and Research Hospital, Izmir\/TURKEY with 2021\/05\u201312 approval number. The Clinical Trials ID number of this study is NCT05525442. The study was performed in accordance with the Declaration of Helsinki and all patients\u2019 written informed consents were taken after oral and written explanations were made.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"143"}}